logo

For the Inventor, By the Inventor

Riyadh, Saudi Arabia

Mohamed Abdulrahman Al-Omar

USPTO Granted Patents = 17

Average Co-Inventor Count = 3.1

ph-index = 3

Forward Citations = 16(Granted Patents)


Company Filing History:

goldMedal17 out of 729 
 
King Saud University
 patents

Years Active: 2014-2019

Loading Chart...
17 patents (USPTO):Explore Patents
1. 10343997 - Ursolic acid derivatives (2019-07-09),
2. 10329249 - Sulindac derivatives (2019-06-25),
3. 10239875 - Naphthyridinyl hydrazine derivatives as potent peripheral analgesic agents (2019-03-26),
4. 10137138 - Sulfonylurea derivatives of oleanolic acid (2018-11-27),
5. 10100054 - Pyrido[2,3-d]pyrimidines as anticancer agents (2018-10-16),
6. 10064837 - Abietic acid derivatives as anti-tumor agents (2018-09-04),
7. 10052326 - Antihepatotoxic agents (2018-08-21),
8. 10047071 - Dihydropyrimidinone derivatives (2018-08-14),
9. 10039749 - Substituted pyrazole derivatives (2018-08-07),
10. 9975917 - Pentacyclic triterpenoidal derivatives (2018-05-22),
11. 9969768 - Oleanolic acid methyl ester derivatives (2018-05-15),
12. 9896476 - Glycyrrhetic acid derivatives (2018-02-20),
13. 9856232 - Dihydropyrimidinone derivatives (2018-01-02),
14. 9855255 - Substituted naphthyridinyl hydrazines as anti-liver cancer agents (2018-01-02),
15. 9808443 - Cyclooxygenase inhibitors (2017-11-07),

Title: Innovations by Inventor Mohamed Abdulrahman Al-Omar

Introduction

Mohamed Abdulrahman Al-Omar is a prominent inventor based in Riyadh, Saudi Arabia. With an impressive portfolio of 17 patents, he has made significant contributions to the field of pharmaceutical innovations. His work focuses on developing novel compounds that have the potential to treat various medical conditions.

Latest Patents

Among his latest innovations are the ursolic acid derivatives, which exhibit potent selective calcium channel blocker activities. These compounds can be beneficial in treating diseases where calcium channel regulation is crucial. Furthermore, Al-Omar has also developed sulindac derivatives. These compounds, characterized by their unique structural formula, can be utilized in pharmaceutical compositions for treating inflammation, analgesia, and gastric sparing properties. His methodological approach includes synthesizing these sulindac derivatives by refluxing sulindac hydrazide with substituted benzaldehydes in the presence of ethanol and glacial acetic acid.

Career Highlights

Mohamed Abdulrahman Al-Omar currently works at King Saud University, where he applies his expertise to advance research and encourage innovation in the field of pharmaceuticals. His career is distinguished not only by the number of patents he holds but also by the impact of his inventions on medical treatments.

Collaborations

Throughout his career, Al-Omar has collaborated with esteemed colleagues such as Abd El-Galil E Amr and Mashooq Ahmad Bhat. These collaborations have contributed to his success in the development of new and effective pharmaceutical compounds.

Conclusion

In summary, inventor Mohamed Abdulrahman Al-Omar continues to represent the forefront of innovation in pharmaceuticals. With an impressive list of patents and ongoing research, his contributions hold promise for advancing medical treatment options. The combination of his innovative ideas and collaborative efforts underscores his significant role in the field of inventions and patent development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…